The AHA today expressed support for the Opioid Workforce Treatment Act of 2018 (H.R. 5818/S. 2843), bipartisan, bicameral legislation that would reduce the shortage of opioid treatment providers by increasing the number of Medicare-funded residency slots in hospitals with programs focused on substance use disorder treatment. A recent report from the National Academies of Sciences, Engineering and Medicine highlighted the dearth of clinicians with specialized training in Medication Assisted Treatment, and the Substance Abuse and Mental Health Services Administration has estimated that only 10% of the 22 million Americans with a SUD receive treatment. “Your legislation would address these shortages by providing 1,000 additional Medicare-funded residency positions in approved residency programs in addiction medicine, addiction psychiatry or pain management,” AHA said in letters of support to the bills’ sponsors. “These new slots would constitute a major step toward increasing access to SUD treatment for communities in need.”

Related News Articles

Headline
The Centers for Medicare & Medicaid Services today released an updated tool for viewing and comparing opioid prescribing rates over time and across regions.
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic last week held a webinar on the work it will undertake over the…
Headline
The AHA today unveiled a set of principles to he
Insights and Analysis
Harney District Hospital, Burns, Ore., is one of many hospitals nationwide that have embraced the Lean mentality, modeled after Toyota’s discipline of lean…
Headline
National hospital organizations, including the AHA, today urged congressional leaders to delay the start of the Medicaid disproportionate share hospital cuts…
Headline
The AHA today urged the Centers for Medicare…